Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

MLTX US Equity

MoonLake ImmunotherapeuticsHealth Care · Pharmaceutical Preparations · CIK 1821586 · FY ends Dec 31
$16.74
+0.40 (+2.45%)
USD · as of 2026-08-19 · marketstack
2 8-K filings · 0 13D · 3 13G
DateEventWhat happened / filerSource
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Cormorant Asset Management, LPsec.gov ↗
2026-08-1413GSchedule 13G filed — ≥5% beneficial owner (passive) · by T. Rowe Price Investment Management, Inc.sec.gov ↗
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Deep Track Capital, LPsec.gov ↗
2026-08-108-K 7.01Regulation FD disclosuresec.gov ↗
2026-08-108-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-07-148-K 8.01Other eventssec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-14

Every row is a filed document, checked against its EDGAR index.